Michael Dixon, Ph.D.
President and CEO, UNeMed Corporation
Dr. Michael Dixon is president and CEO of UNeMed, a non-profit company that works with faculty, students and staff of the University of Nebraska Medical Center (UNMC), the University of Nebraska at Omaha, and Nebraska Medicine to help commercialize innovative, new ideas that have the potential to improve public health.
Dr. Dixon’s tenure at UNMC began in 1998 when he joined the Eppley Institute for Research in Cancer and Allied Diseases where he focused on his research interests in the areas of molecular biology, genetics, and biochemistry.
Dr. Dixon is a graduate of Leadership Omaha Class 32 and a 2011 recipient of the Midlands Business Journal “40 under 40” award. He is also a member of the Board of Directors for Invest Nebraska, a non-profit, venture development organization that advises and invests in early stage, high growth Nebraska companies.